At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth
21 July 2023, 6:41 pm 1 minute
Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale.
Market Impact
Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million. They are up 63.9% year-to-date, outperforming an 18.2% rise in the S&P 500 Index.
Article Tags
Topics of Interest: Business & FinanceDealsHealth
Type: Reuters Best
Sectors: Business & FinancePharmaceuticals & Healthcare
Regions: Americas
Countries: United States
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story
